ConductScience.org, home

Paper15531908

Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.

Gibo J and 8 others. Lab Invest, 2005. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Papers, record 15531908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15531908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
PubMed
Journal
Lab Invest
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2023-02-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gibo JJunya
2Ito TTetsuhide
3Kawabe KKen
4Hisano TTerumasa
5Inoue MMasanobu
6Fujimori NNao
7Oono TTakamasa
8Arita YYoshiyuki
9Nawata HHajime

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrosisMajor topic
GabexateMajor topic
MonocytesMajor topic
PancreasMajor topic
PancreatitisMajor topic
Protease InhibitorsMajor topic
Animals
Cell Proliferation
Chemokine CCL2
Disease Models, Animal
Dose-Response Relationship, Drug
Esters
Guanidines
Male
Organotin Compounds
Procollagen
RNA, Messenger
Rats
Rats, Inbred Lew
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
40973081Large Library Docking and Biophysical Analysis of Small-Molecule TMPRSS2 Inhibitors.J Med Chem2025https://conductscience.org/library/papers/40973081PubMed
40227431Phase 2 Open-label, Single-arm, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Camostat Mesylate in Patients with Protein-losing Enteropathy After Fontan Operation.Pediatr Cardiol2026https://conductscience.org/library/papers/40227431PubMed
39858469TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses.Biomolecules2025https://conductscience.org/library/papers/39858469PubMed
37081137Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.Eur J Clin Pharmacol2023https://conductscience.org/library/papers/37081137PubMed
37059487Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.J Pharmacol Sci2023https://conductscience.org/library/papers/37059487PubMed
36857133Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective.J Med Chem2023https://conductscience.org/library/papers/36857133PubMed
36515544A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/36515544PubMed
35713329Tailored Phenyl Esters Inhibit ClpXP and Attenuate Staphylococcus aureus α-Hemolysin Secretion.Chembiochem2022https://conductscience.org/library/papers/35713329PubMed
35641023Drug repurposing for the treatment of COVID-19.J Pharmacol Sci2022https://conductscience.org/library/papers/35641023PubMed
35423713Immune response and possible therapeutics in COVID-19.RSC Adv2020https://conductscience.org/library/papers/35423713PubMed
35072549The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.Expert Opin Drug Discov2022https://conductscience.org/library/papers/35072549PubMed
34527443Camostat mesilate inhibits pro-inflammatory cytokine secretion and improves cell viability by regulating MFGE8 and HMGN1 in lipopolysaccharide-stimulated DF-1 chicken embryo fibroblasts.PeerJ2021https://conductscience.org/library/papers/34527443PubMed
34485853SARS-Cov-2: Biology, Detection, Macrophage Mediated Pathogenesis and Potential Treatments.Virol Immunol J2020https://conductscience.org/library/papers/34485853PubMed
34295715Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications.Cardiovasc Diagn Ther2021https://conductscience.org/library/papers/34295715PubMed
33369210Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract.Pharmacol Res Perspect2021https://conductscience.org/library/papers/33369210PubMed
33290397Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.PLoS Comput Biol2020https://conductscience.org/library/papers/33290397PubMed
33234691Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1.Sci Signal2020https://conductscience.org/library/papers/33234691PubMed
33225308Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation.Crit Care Explor2020https://conductscience.org/library/papers/33225308PubMed
33112126Targeting Crucial Host Factors of SARS-CoV-2.ACS Infect Dis2020https://conductscience.org/library/papers/33112126PubMed
32693756Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.Curr Med Chem2021https://conductscience.org/library/papers/32693756PubMed

See all 40 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15531908

GET https://conductscience.org/api/papers/v1/15531908/cited_by?page=2